162 related articles for article (PubMed ID: 24681704)
1. Monitoring anticoagulation in patients with an unreliable prothrombin time/international normalized ratio: factor II versus chromogenic factor X testing.
Baumann Kreuziger LM; Datta YH; Johnson AD; Zantek ND; Shanley R; Reding MT
Blood Coagul Fibrinolysis; 2014 Apr; 25(3):232-6. PubMed ID: 24681704
[TBL] [Abstract][Full Text] [Related]
2. Factor X and factor II activity levels do not always agree in warfarin-treated lupus anticoagulant patients.
Rosborough TK; Jacobsen JM; Shepherd MF
Blood Coagul Fibrinolysis; 2010 Apr; 21(3):242-4. PubMed ID: 20182349
[TBL] [Abstract][Full Text] [Related]
3. During warfarin induction, the Fiix-prothrombin time reflects the anticoagulation level better than the standard prothrombin time.
Jonsson PI; Letertre L; Juliusson SJ; Gudmundsdottir BR; Francis CW; Onundarson PT
J Thromb Haemost; 2017 Jan; 15(1):131-139. PubMed ID: 27774726
[TBL] [Abstract][Full Text] [Related]
4. Warfarin monitoring in antiphospholipid syndrome and lupus anticoagulant.
Crowl A; Schullo-Feulner A; Moon JY
Ann Pharmacother; 2014 Nov; 48(11):1479-83. PubMed ID: 25104566
[TBL] [Abstract][Full Text] [Related]
5. Usefulness of factor II and factor X as therapeutic markers in patients under chronic warfarin therapy.
Costa IM; Serralheiro AI; Rodrigues M; Alves G; Falcão AC
Biomed Pharmacother; 2010 Feb; 64(2):130-2. PubMed ID: 20045627
[TBL] [Abstract][Full Text] [Related]
6. Contributions of procoagulants and anticoagulants to the international normalized ratio and thrombin generation assay in patients treated with warfarin: potential role of protein Z as a powerful determinant of coagulation assays.
Choi Q; Kim JE; Hyun J; Han KS; Kim HK
Thromb Res; 2013 Jul; 132(1):e70-5. PubMed ID: 23769659
[TBL] [Abstract][Full Text] [Related]
7. Relationship between international normalized ratio values, vitamin K-dependent clotting factor levels and in vivo prothrombin activation during the early and steady phases of oral anticoagulant treatment.
D'Angelo A; Della Valle P; Crippa L; Fattorini A; Pattarini E; Viganò D'Angelo S
Haematologica; 2002 Oct; 87(10):1074-80. PubMed ID: 12368163
[TBL] [Abstract][Full Text] [Related]
8. Relationship between chromogenic factor X and international normalized ratio differs during early warfarin initiation compared with chronic warfarin administration.
Rosborough TK; Jacobsen JM; Shepherd MF
Blood Coagul Fibrinolysis; 2009 Sep; 20(6):433-5. PubMed ID: 19543077
[TBL] [Abstract][Full Text] [Related]
9. Monitoring anticoagulant therapy with vitamin K antagonists in patients with antiphospholipid syndrome.
Isert M; Miesbach W; Schüttfort G; Weil Y; Tirneci V; Kasper A; Weber A; Lindhoff-Last E; Herrmann E; Linnemann B
Ann Hematol; 2015 Aug; 94(8):1291-9. PubMed ID: 25859986
[TBL] [Abstract][Full Text] [Related]
10. Comparison of a chromogenic factor X assay with international normalized ratio for monitoring oral anticoagulation therapy.
McGlasson DL; Romick BG; Rubal BJ
Blood Coagul Fibrinolysis; 2008 Sep; 19(6):513-7. PubMed ID: 18685434
[TBL] [Abstract][Full Text] [Related]
11. Thrombin generation and factor X assays for the assessment of warfarin anticoagulation in thrombotic antiphospholipid syndrome.
Efthymiou M; Lawrie AS; Mackie I; Arachchillage D; Lane PJ; Machin S; Cohen H
Thromb Res; 2015 Jun; 135(6):1191-7. PubMed ID: 25895847
[TBL] [Abstract][Full Text] [Related]
12. Critical role of factors II and X during coumarin anticoagulation and their combined measurement with a new Fiix-prothrombin time.
Gudmundsdottir BR; Francis CW; Bjornsdottir AM; Nellbring M; Onundarson PT
Thromb Res; 2012 Oct; 130(4):674-81. PubMed ID: 22225856
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of warfarin management with international normalized ratio self-testing and online remote monitoring and management plus low-dose vitamin k with genomic considerations: a pilot study.
Bussey HI; Bussey M; Bussey-Smith KL; Frei CR
Pharmacotherapy; 2013 Nov; 33(11):1136-46. PubMed ID: 24038412
[TBL] [Abstract][Full Text] [Related]
14. Guidance of anticoagulation after intracoronary implantation of Palmaz-Schatz stents by monitoring prothrombin and prothrombin fragment 1 + 2.
Haude M; Hafner G; Jablonka A; Rupprecht HJ; Prellwitz W; Meyer J; Erbel R
Am Heart J; 1995 Aug; 130(2):228-38. PubMed ID: 7631600
[TBL] [Abstract][Full Text] [Related]
15. Use of chromogenic assay of factor X to accept or reject INR results in Warfarin treated patients.
Sanfelippo MJ; Zinsmaster W; Scherr DL; Shaw GR
Clin Med Res; 2009 Sep; 7(3):103-5. PubMed ID: 19625497
[TBL] [Abstract][Full Text] [Related]
16. Extended International Normalized Ratio testing intervals for warfarin-treated patients.
Barnes GD; Kong X; Cole D; Haymart B; Kline-Rogers E; Almany S; Dahu M; Ekola M; Kaatz S; Kozlowski J; Froehlich JB
J Thromb Haemost; 2018 Jul; 16(7):1307-1312. PubMed ID: 29763979
[TBL] [Abstract][Full Text] [Related]
17. Warfarin initiation and monitoring with clotting factors II, VII, and X.
Trask AS; Gosselin RC; Diaz JA; Dager WE
Ann Pharmacother; 2004 Feb; 38(2):251-6. PubMed ID: 14742761
[TBL] [Abstract][Full Text] [Related]
18. [Accuracy and reliability of international normalized ratio (INR) in monitoring of warfarin--comparison in the sensitivity to extrinsic coagulation factors between PT (INR) and TT (INR)].
Sakayori T; Naito S; Yoshida M; Kumano O; Kato N; Okuda M; Ieko M
Rinsho Byori; 2010 Aug; 58(8):779-85. PubMed ID: 20860170
[TBL] [Abstract][Full Text] [Related]
19. Point-of-care testing of the international normalized ratio in patients with antiphospholipid antibodies.
Perry SL; Samsa GP; Ortel TL
Thromb Haemost; 2005 Dec; 94(6):1196-202. PubMed ID: 16411394
[TBL] [Abstract][Full Text] [Related]
20. Contribution of rivaroxaban to the international normalized ratio when switching to warfarin for anticoagulation as determined by simulation studies.
Siegmund HU; Burghaus R; Kubitza D; Coboeken K
Br J Clin Pharmacol; 2015 Jun; 79(6):959-66. PubMed ID: 25510952
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
